InvestorsHub Logo
Followers 33
Posts 9893
Boards Moderated 0
Alias Born 02/26/2016

Re: nidan7500 post# 162428

Tuesday, 08/14/2018 10:53:22 AM

Tuesday, August 14, 2018 10:53:22 AM

Post# of 461814
THAT is the reason IMHO....

Hampel is enthusiastic about, if not totally endorsing, 2-73.

Hampel BELIEVES there are bodily functions which,
if properly targeted, can address individual disease.
I am wholeheartedly behind that hypothesis.

2-73 was shown to actually "enter" and affect S1.
What that may come to mean is WHY we have trials.

I am happy Anavex is seen as relevant in Hampel's world.
I look forward to the results from the process to
determine EFFICACY of 2-73 and its other molecules.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News